Appendix B: Sources of evidence considered by the Committee

A. The assessment report for this appraisal was prepared by the West Midlands Health Technology Assessment Group, University of Birmingham.

Albon E, Tsourapas A, Frew E et al. Structural neuroimaging in psychosis. Systematic review and economic evaluation, June 2007

B. The following organisations accepted the invitation to participate in this appraisal. They were invited to comment on the draft scope, the assessment report and the appraisal consultation document (ACD). Organisations listed in I and II were also invited to make written submissions and have the opportunity to appeal against the Final Appraisal Determination.

I) Manufacturers/sponsors:

GE Medical Systems
Phillips Medical Systems

II) Professional/specialist and patient/carer groups:

Counsel and Care
Rethink
British Association for Psychopharmacology
British Neuropsychiatry Association
British Psychological Society
Royal of General Practitioners
Royal College of Nursing
Royal of Radiologists

III) Commentator organisations (without the right of appeal):

Department of Health, Social Services and Public Safety for Northern Ireland
EUCOMED
NHS Quality Improvement Scotland
Institute of Psychiatry
National Coordinating Centre for Health Technology Assessment
West Midlands HTA Collaboration

C. The following individuals were selected from clinical specialist and patient advocate nominations from the non-manufacturer/sponsor consultees and commentators. They participated in the Appraisal Committee discussions and provided evidence to inform the Appraisal Committee's deliberations. They gave their expert personal view on structural neuroimaging by attending the initial Committee discussion and/or providing written evidence to the Committee. They were also invited to comment on the ACD.

Professor Philip McGuire, Professor of Psychiatry and Cognitive Neuroscience, Institute – clinical specialist
Dr Sophia Frangou, Reader, Institute – clinical specialist